HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 67833Erstellt: 25. Oktober 2026
Morpholine → p-Nitrobenzyl alpha-[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-alpha-(1-morpholino-2-bromoethylidene)acetate
https://huagongshe.com/reaction/67833

Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Morpholine | HCID 8083 | — |
| Edukt | Bromine | HCID 24408 | — |
| Edukt | Methanesulfonyl chloride | HCID 31297 | — |
| Edukt | Sodium Bicarbonate | HCID 516892 | — |
| Edukt | p-Nitrobenzyl alpha-[3-phenoxymethyl-7-oxo4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-alpha-(1-hydroxyethylidene)acetate | HCID 70504145 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Lösungsmittel | Carbon Tetrachloride | HCID 5943 | — |
| Lösungsmittel | Dichloromethane | HCID 6344 | — |
| Lösungsmittel | Triethylamine | HCID 8471 | — |
| Produkt | p-Nitrobenzyl alpha-[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6yl]-alpha-methanesulfonyl-alpha-acetylacetate | HCID 12961193 | 12,2% |
| Produkt | p-Nitrobenzyl alpha-[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-alpha-(1-morpholino-2-bromoethylidene)acetate | HCID 54184089 | 69% |
Reaktionsschritte
One dissolves p-nitrobenzyl α-[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-α-(1-hydroxyethylidene)acetate (940 mg) in dichloromethane (14 ml), cools to -25° C., adds triethylamine (0.61 ml) and methanesulfonyl chloride (0.17 ml), and stirs for 1.5 hours. To the solution, one adds morpholine (0.209 ml), keeps at -25° C. for 1.5 hours, adds bromine (2.2 mmol) dissolved in carbon tetrachloride (2.2 ml) and after 30 minutes at -25° C., adds 5% aqueous sodium hydrogen carbonate, washes with water, dries and evaporates. Purification of the obtained residue (1.134 g) by chromatography over silica gel containing 10% water (100 g) using a mixture of benzene and ethyl acetate (3:1) gives p-nitrobenzyl α-[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-α-(1-morpholino-2-bromoethylidene)acetate (852.6 mg; 69%) and p-nitrobenzyl α -[3-phenoxymethyl-7-oxo-4-thia-2,6-diazabicyclo[3,2,0]hept-2-en-6-yl]-α-methanesulfonyl-α-acetylacetate (1332.2 mg; 12.2%).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US04346218 |
|---|
| Quelldatensatz | uspto-grants-1982_08 |
|---|
| ORD ID | ord-da6c52de4a3c4ddd8d07e4271ddd0713 |
|---|
| Quellennotiz | uspto-grants-1982_08 |
|---|